Literature DB >> 21270402

TANK-binding kinase 1 attenuates PTAP-dependent retroviral budding through targeting endosomal sorting complex required for transport-I.

Qi Da1, Xuanming Yang, Youli Xu, Guangxia Gao, Genhong Cheng, Hong Tang.   

Abstract

Retroviruses need to bud from producer cells to spread infection. To facilitate its budding, some virus hijacks the multivesicular body (MVB) pathway that is normally used to cargo and degrade ubiquitylated cellular proteins, through interaction between the late domain of Gag polyproteins and the components of MVB machinery. In this study, we demonstrated that TANK-binding kinase 1 (TBK1) directly interacted with VPS37C, a subunit of endosomal sorting complex required for transport-I (ESCRT-I) in the MVB pathway, without affecting the ultrastructure or general function of MVB. Interestingly, overexpression of TBK1 attenuated, whereas short hairpin RNA interference of TBK1 enhanced HIV-1 pseudovirus release from Vero cells in type I IFN (IFN-I)-independent manner. Down-regulation of TBK1 by short hairpin RNA in TZM-bl cells also enhanced live HIV-1 NL4-3 or JR-CSF virus budding without involvement of IFN-I induction. Furthermore, infection of TBK1-deficient mouse embryonic fibroblast cells with a chimeric murine leukemia virus/p6, whose PPPY motif was replaced by PTAP motif of HIV-1, showed that lack of TBK1 significantly enhanced PTAP-dependent, but not PPPY-dependent retrovirus budding. Finally, phosphorylation of VPS37C by TBK1 might regulate the viral budding efficiency, because overexpression of the kinase-inactive mutant of TBK1 (TBK1-K38A) in Vero cells accelerated HIV-1 pseudovirus budding. Therefore, through tethering to VPS37C of the ESCRT-I complex, TBK1 controlled the speed of PTAP-dependent retroviral budding through phosphorylation of VPS37C, which would serve as a novel mechanism of host cell defense independent of IFN-I signaling.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21270402      PMCID: PMC4309384          DOI: 10.4049/jimmunol.1000262

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  49 in total

1.  HIV-1 and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress.

Authors:  J Martin-Serrano; T Zang; P D Bieniasz
Journal:  Nat Med       Date:  2001-12       Impact factor: 53.440

Review 2.  The HIV-1 assembly machine.

Authors:  H G Göttlinger
Journal:  AIDS       Date:  2001       Impact factor: 4.177

3.  IKK-i and TBK-1 are enzymatically distinct from the homologous enzyme IKK-2: comparative analysis of recombinant human IKK-i, TBK-1, and IKK-2.

Authors:  Nandini Kishore; Q Khai Huynh; Sumathy Mathialagan; Troii Hall; Sharon Rouw; David Creely; Gary Lange; James Caroll; Beverley Reitz; Ann Donnelly; Hymavathi Boddupalli; Rodney G Combs; Kuniko Kretzmer; Catherine S Tripp
Journal:  J Biol Chem       Date:  2002-02-11       Impact factor: 5.157

4.  Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding.

Authors:  J E Garrus; U K von Schwedler; O W Pornillos; S G Morham; K H Zavitz; H E Wang; D A Wettstein; K M Stray; M Côté; R L Rich; D G Myszka; W I Sundquist
Journal:  Cell       Date:  2001-10-05       Impact factor: 41.582

Review 5.  Viral late domains.

Authors:  Eric O Freed
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

6.  Overexpression of the N-terminal domain of TSG101 inhibits HIV-1 budding by blocking late domain function.

Authors:  Dimiter G Demirov; Akira Ono; Jan M Orenstein; Eric O Freed
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

7.  Deficiency of T2K leads to apoptotic liver degeneration and impaired NF-kappaB-dependent gene transcription.

Authors:  M Bonnard; C Mirtsos; S Suzuki; K Graham; J Huang; M Ng; A Itié; A Wakeham; A Shahinian; W J Henzel; A J Elia; W Shillinglaw; T W Mak; Z Cao; W C Yeh
Journal:  EMBO J       Date:  2000-09-15       Impact factor: 11.598

8.  NF-kappaB activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK-related kinase.

Authors:  J L Pomerantz; D Baltimore
Journal:  EMBO J       Date:  1999-12-01       Impact factor: 11.598

9.  Tsg101, a homologue of ubiquitin-conjugating (E2) enzymes, binds the L domain in HIV type 1 Pr55(Gag).

Authors:  L VerPlank; F Bouamr; T J LaGrassa; B Agresta; A Kikonyogo; J Leis; C A Carter
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-26       Impact factor: 11.205

10.  The TBK1 adaptor and autophagy receptor NDP52 restricts the proliferation of ubiquitin-coated bacteria.

Authors:  Teresa L M Thurston; Grigory Ryzhakov; Stuart Bloor; Natalia von Muhlinen; Felix Randow
Journal:  Nat Immunol       Date:  2009-10-11       Impact factor: 25.606

View more
  5 in total

1.  Crystal structure of the ubiquitin-like domain of human TBK1.

Authors:  Jian Li; Jun Li; Andrea Miyahira; Jian Sun; Yingfang Liu; Genhong Cheng; Huanhuan Liang
Journal:  Protein Cell       Date:  2012-05-20       Impact factor: 14.870

2.  TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions.

Authors:  Charles A S Banks; Gina Boanca; Zachary T Lee; Cassandra G Eubanks; Gaye L Hattem; Allison Peak; Lauren E Weems; Juliana J Conkright; Laurence Florens; Michael P Washburn
Journal:  Mol Cell Proteomics       Date:  2016-09-08       Impact factor: 5.911

3.  A role for myocilin in receptor-mediated endocytosis.

Authors:  Brian S McKay; Nicole R Congrove; Adiv A Johnson; W Michael Dismuke; Trent J Bowen; W Daniel Stamer
Journal:  PLoS One       Date:  2013-12-18       Impact factor: 3.240

4.  Loss of TBK1 is a frequent cause of frontotemporal dementia in a Belgian cohort.

Authors:  Ilse Gijselinck; Sara Van Mossevelde; Julie van der Zee; Anne Sieben; Stéphanie Philtjens; Bavo Heeman; Sebastiaan Engelborghs; Mathieu Vandenbulcke; Greet De Baets; Veerle Bäumer; Ivy Cuijt; Marleen Van den Broeck; Karin Peeters; Maria Mattheijssens; Frederic Rousseau; Rik Vandenberghe; Peter De Jonghe; Patrick Cras; Peter P De Deyn; Jean-Jacques Martin; Marc Cruts; Christine Van Broeckhoven
Journal:  Neurology       Date:  2015-11-18       Impact factor: 9.910

5.  Quinolinate Phosphoribosyltransferase is an Antiviral Host Factor Against Hepatitis C Virus Infection.

Authors:  Zhilong Wang; Yanhang Gao; Chao Zhang; Haiming Hu; Dongwei Guo; Yi Xu; Qiuping Xu; Weihong Zhang; Sisi Deng; Pingyun Lv; Yan Yang; Yanhua Ding; Qingquan Li; Changjiang Weng; Xinwen Chen; Sitang Gong; Hairong Chen; Junqi Niu; Hong Tang
Journal:  Sci Rep       Date:  2017-07-19       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.